Health
Mayo Clinic researchers develop test to measure effect of breast cancer gene variants – Newswise
Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene w
Newswise — ROCHESTER, Minn. Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS). The findings were published today in a study in the American Journal of Human Genetics.
“There are 4,565 different VUS in the BRCA2 gene listed in the National…
-
Noosa News22 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Noosa News24 hours agoMeasles alert issued across popular south-east attractions
-
General24 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Business11 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025